Intramuscular bioavailability of chlorazepate as compared to diazepam
- PMID: 2859206
- DOI: 10.1007/BF00609698
Intramuscular bioavailability of chlorazepate as compared to diazepam
Abstract
Dipotassium chlorazepate (DPC) and diazepam (DZM) were given i.m. and i.v. to 6 healthy volunteers in doses of 20 mg (48.9 mumol) DPC and 15 mg (52.0 mumol) DZM. The interval between the injections was at least 1 week. Plasma samples were analyzed for DPC and DZM by HPLC. The bioavailability of DPC and DZM after i.m. administration, determined from computer calculated AUCs, was 1.04 and 0.85, respectively.
Similar articles
-
Pharmacokinetics of chlorazepate after intravenous and intramuscular administration.Psychopharmacology (Berl). 1983;80(3):236-9. doi: 10.1007/BF00436160. Psychopharmacology (Berl). 1983. PMID: 6137019
-
[Pharmacokinetic studies after oral and parenteral application of dipotassium chlorazepate (author's transl)].Arzneimittelforschung. 1982;32(3):272-5. Arzneimittelforschung. 1982. PMID: 6123331 German.
-
[Bioavailability of chlorazepate dipotassium (Tranxene) presented in various oral dosage forms].Pharm Acta Helv. 1984;59(7):191-9. Pharm Acta Helv. 1984. PMID: 6147858 French. No abstract available.
-
The use of benzodiazepines in clinical practice.Br J Clin Pharmacol. 1981;11 Suppl 1(Suppl 1):5S-9S. doi: 10.1111/j.1365-2125.1981.tb01832.x. Br J Clin Pharmacol. 1981. PMID: 6133535 Free PMC article. Review.
-
Pharmacokinetics in clinical medicine: oxazepam versus other benzodiazepines.Dis Nerv Syst. 1975 May;36(5 Pt. 2):6-13. Dis Nerv Syst. 1975. PMID: 1095326 Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources